13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Effect of a Face-Aging Mobile App–Based Intervention on Skin Cancer Protection Behavior in Secondary Schools in Brazil : A Cluster-Randomized Clinical Trial

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This randomized clinical trial assesses the effect of the free face-aging mobile app Sunface on the skin cancer protection behavior of adolescents in Brazil.

          Key Points

          Question

          Can a face-aging mobile app improve the skin cancer protection behavior of secondary school students?

          Findings

          In this cluster-randomized clinical trial of 52 school classes with 1573 Brazilian pupils, meaningful improvements were observed in sunscreen use, tanning behavior, and skin self-examinations 3 to 6 months after an intervention using a face-aging app compared with the nonintervention group.

          Meaning

          Face-aging apps may be useful tools to increase skin cancer protection in adolescents and thereby decrease skin cancer risk.

          Abstract

          Importance

          Because exposure to UV radiation early in life is an important risk factor for melanoma development, reducing UV exposure in children and adolescents is of paramount importance. New interventions are urgently required.

          Objective

          To determine the effect of the free face-aging mobile app Sunface on the skin cancer protection behavior of adolescents.

          Design, Setting, and Participants

          This cluster-randomized clinical trial included a single intervention and a 6-month follow-up from February 1 to November 30, 2018. Randomization was performed on the class level in 52 school classes within 8 public secondary schools (grades 9-12) in Itauna, Southeast Brazil. Data were analyzed from May 1 to October 10, 2019.

          Interventions

          In a classroom seminar delivered by medical students, adolescents’ selfies were altered by the app to show UV effects on their future faces and were shown in front of their class, accompanied by information about UV protection. Information about relevant parameters was collected via anonymous questionnaires before and 3 and 6 months after the intervention.

          Main Outcomes and Measures

          The primary end point of the study was the difference in daily sunscreen use at 6 months of follow-up. Secondary end points included the difference in daily sunscreen use at 3 months of follow-up, at least 1 skin self-examination within 6 months, and at least 1 tanning session in the preceding 30 days. All analyses were predefined and based on intention to treat. Cluster effects were taken into account.

          Results

          Participants included 1573 pupils (812 girls [51.6%] and 761 boys [48.4%]; mean [SD] age, 15.9 [1.3] years) from 52 school classes. Daily sunscreen use increased from 110 of 734 pupils (15.0%) to 139 of 607 (22.9%; P < .001) at the 6-month follow-up in the intervention group. The proportion of pupils performing at least 1 skin self-examination in the intervention group rose from 184 of 734 (25.1%) to 300 of 607 (49.4%; P < .001). Use of tanning decreased from 138 of 734 pupils (18.8%) to 92 of 607 (15.2%; P = .04). No significant changes were observed in the control group. The intervention was more effective for female students (number needed to treat for the primary end point: 8 for girls and 31 for boys).

          Conclusions and Relevance

          These findings suggest that interventions based on face-aging apps may increase skin cancer protection behavior in Brazilian adolescents. Further studies are required to maximize the effect and to investigate the generalizability of the effects.

          Trial Registration

          ClinicalTrials.gov Identifier: NCT03178240

          Related collections

          Most cited references28

          • Record: found
          • Abstract: found
          • Article: not found

          Sunscreen Use and Subsequent Melanoma Risk: A Population-Based Cohort Study.

          Purpose To assess melanoma risk in relation to sunscreen use and to compare high- with low-sun protection factor (SPF) sunscreens in relation to sunbathing habits in a large cohort study. Materials and Methods We used data from the Norwegian Women and Cancer Study, a prospective population-based study of 143,844 women age 40 to 75 years at inclusion with 1,532,247 person-years of follow-up and 722 cases of melanoma. Multivariable Cox proportional hazards regression was used to estimate the association between sunscreen use (never, SPF < 15, SPF ≥ 15) and melanoma risk by calculating hazard ratios and 95% CIs. The population attributable fraction associated with sunscreen use was estimated. Results Sunscreen users reported significantly more sunburns and sunbathing vacations and were more likely to use indoor tanning devices. SPF ≥ 15 sunscreen use was associated with significantly decreased melanoma risk compared with SPF < 15 use (hazard ratio, 0.67; 95% CI, 0.53 to 0.83). The estimated decrease in melanoma (population attributable fraction) with general use of SPF ≥ 15 sunscreens by women age 40 to 75 years was 18% (95% CI, 4% to 30%). Conclusion Use of SPF ≥ 15 rather than SPF < 15 sunscreens reduces melanoma risk. Moreover, use of SPF ≥ 15 sunscreen by all women age 40 to 75 years could potentially reduce their melanoma incidence by 18%.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Long-term ultraviolet flux, other potential risk factors, and skin cancer risk: a cohort study.

            Few prospective studies have examined the relationship between sun exposure, other potential risk factors, and risk of different skin cancers [including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma] simultaneously.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Confidence interval estimation of the intraclass correlation coefficient for binary outcome data.

              We obtain closed-form asymptotic variance formulae for three point estimators of the intraclass correlation coefficient that may be applied to binary outcome data arising in clusters of variable size. Our results include as special cases those that have previously appeared in the literature (Fleiss and Cuzick, 1979, Applied Psychological Measurement 3, 537-542; Bloch and Kraemer, 1989, Biometrics 45, 269-287; Altaye, Donner, and Klar, 2001, Biometrics 57, 584-588). Simulation results indicate that confidence intervals based on the estimator proposed by Fleiss and Cuzick provide coverage levels close to nominal over a wide range of parameter combinations. Two examples are presented.
                Bookmark

                Author and article information

                Journal
                JAMA Dermatol
                JAMA Dermatol
                JAMA Dermatol
                JAMA Dermatology
                American Medical Association
                2168-6068
                2168-6084
                July 2020
                6 May 2020
                6 May 2020
                : 156
                : 7
                : 737-745
                Affiliations
                [1 ]Department of Dermatology, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany
                [2 ]School of Medicine, University of Itauna, Itauna, Brazil
                [3 ]Department of Dermatology, Venerology and Allergology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
                [4 ]Department of Dermatology, Heidelberg University, Mannheim, Germany
                [5 ]Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany
                [6 ]Cancer Prevention Unit, German Cancer Research Center, Heidelberg, Germany
                [7 ]School of Medicine, Federal University of Ouro Preto, Ouro Preto, Brazil
                Author notes
                Article Information
                Accepted for Publication: March 13, 2020.
                Published Online: May 6, 2020. doi:10.1001/jamadermatol.2020.0511
                Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2020 Brinker TJ et al. JAMA Dermatology .
                Corresponding Author: Titus J. Brinker, MD, Department of Dermatology, National Center for Tumor Diseases, German Cancer Research Center, Im Neuenheimer Feld 460, Heidelberg 69120, Germany ( titus.brinker@ 123456dkfz.de ).
                Author Contributions: Drs Brinker and Bernardes-Souza had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
                Concept and design: Brinker, Faria, de Faria, Schadendorf, Lisboa, Oliveira, Lino, Bernardes-Souza.
                Acquisition, analysis, or interpretation of data: Brinker, Faria, de Faria, Klode, Utikal, Mons, Krieghoff-Henning, Oliveira, Lino, Bernardes-Souza.
                Drafting of the manuscript: Brinker, Faria, de Faria, Mons, Krieghoff-Henning, Lisboa, Oliveira, Lino, Bernardes-Souza.
                Critical revision of the manuscript for important intellectual content: Brinker, Faria, de Faria, Klode, Schadendorf, Utikal, Mons, Krieghoff-Henning, Oliveira, Lino, Bernardes-Souza.
                Statistical analysis: Brinker.
                Obtained funding: Brinker, Oliveira.
                Administrative, technical, or material support: Brinker, Faria, de Faria, Schadendorf, Utikal, Lisboa, Oliveira, Lino, Bernardes-Souza.
                Supervision: Brinker, Faria, de Faria, Klode, Lisboa, Oliveira, Lino, Bernardes-Souza.
                Conflict of Interest Disclosures: Dr Brinker reported receiving the Young Research Award from La Fondation la Roche-Posay for his research on the Sunface app and is the owner of Smart Health Heidelberg GmbH outside the submitted work. Dr Schadendorf reported receiving grants, personal fees, and nonfinancial support from Bristol-Myers Squibb; personal fees and nonfinancial support from Roche; grants, personal fees, and nonfinancial support from Novartis International AG; nonfinancial support from Regeneron; personal fees from Sanofi; personal fees and nonfinancial support from Merck Sharp & Dohme; personal fees and nonfinancial support from Merck–EMD Sereno; personal fees and nonfinancial support from 4SC; personal fees from Array BioPharma; personal fees and nonfinancial support from Pierre Fabre; personal fees and nonfinancial support from Philogen; personal fees and nonfinancial support from Incyte; and personal fees from Pfizer, Inc, outside the submitted work. Dr Utikal reported personal fees from honoraria and travel support from Amgen, Inc, Bristol-Myers Squibb, GlaxoSmithKline, LEO Pharma AS, Merck Sharp & Dohme, Novartis International AG, Pierre Fabre, Roche, and Sanofi and grants from Apogenix, Noxxon Pharma, Elsalys Biotech, TILT Biotherapeutics, BioNTech RNA Pharmaceuticals GmbH, RHEACELL, and Merck & Co outside the submitted work. Dr Krieghoff-Henning reported working for Dr Brinker for another independent project at the German Cancer Research Center. No other disclosures were reported.
                Funding/Support: This research was financially supported by the Young Research Award from La Fondation la Roche-Posay (Dr Brinker for research on the Sunface app) and by the University of Itauna.
                Role of the Funder/Sponsor: The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication
                Data Sharing Statement: See Supplement 3 .
                Additional Contributions: We thank all participating schools, teachers, and volunteering medical students who helped to organize the classroom visits in the city of Itauna. Lea Herzig, MD, a resident in the Department of Neurosurgery at the University Hospital Schleswig-Holstein, granted permission to publish her photograph.
                Article
                doi200014
                10.1001/jamadermatol.2020.0511
                7203674
                32374352
                e894e253-910a-42b4-9bb4-9866df198ef1
                Copyright 2020 Brinker TJ et al. JAMA Dermatology .

                This is an open access article distributed under the terms of the CC-BY License.

                History
                : 18 December 2019
                : 13 March 2020
                Categories
                Research
                Research
                Original Investigation
                Featured
                Online First
                Comments

                Comments

                Comment on this article